NCE articles & resources on Made-in-China.com

Piramal Won Its Fourth Consecutive Gold Award in The Large Industry Segment

Nov 15, 2013

Leading glass container manufacturer, Piramal Glass Ceylon PLC (PGC) has recently won its fourth consecutive Gold award in the Large Industry segment in the Ceramic sector at the recently concluded NCE awards ceremony. In addition to this, ...

Tags: NCE, award, piramal, PGC

PGC Becomes The Most Preferred Specialty Glass Packaging Solutions Provider in Asia

Sep 30, 2013

Piramal Glass Ceylon is steadily moving towards realizing its vision of being the most preferred specialty glass packaging solutions provider in Asia by meeting customer expectation through innovative designs and manufacturing, said Sanjay ...

Tags: Construction, Decoration

TaiGen Biotechnology Has Submitted New Drug Application

May 22, 2013

TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan Food and Drug Administration (TFDA) and China Food and Drug Administration (CFDA). Nemonoxacin is the first ...

Tags: TaiGen Biotechnology, Medicine

SLP Released Admet Predictor Version 6.0 for Molecular Property Predictions From Structure

Dec 3, 2012

Simulations Plus (SLP), a provider of simulation and modeling software for pharmaceutical discovery and development, has released Admet Predictor Version 6.0 for molecular property predictions from structure. Admet Predictor 6.0 now ...

Tags: URAC, CoramRx, Specialty Pharmacy Services

The Sri Lankan NCE Has Recognized Bureau Veritas to Exporters

Dec 3, 2012

The Sri Lankan National Chamber of Exporters (NCE) has recognized Bureau Veritas as an outstanding Service Provider to Exporters and its contribution to the success of the country's textile manufacturers. Bureau Veritas Consumer Products ...

Tags: textile exporters, textile market, textile industry

Stiefel Has Acquired The Development and Commercialization Rights

Nov 30, 2012

Stiefel, a GSK company, has acquired the development and commercialization rights to Welichem Biotech (WBI) anti-inflammatory agent, WBI-1001. The acquisition follows the previously announced asset purchase agreement. WBI-1001 ...

Tags: acquisition, clinical drugs, Stiefel